Implementation Laboratory

实施实验室

• 批准号: 10683417
• 负责人: Lawrence N. Shulman
• 金额: $ 11.94万
• 依托单位: UNIVERSITY OF PENNSYLVANIA
• 依托单位国家: 美国
• 财政年份: 2020
• 资助国家: 美国
• 起止时间: 2020-08-01 至 2025-07-31
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/10683417
• 关键词: African American; Area; Biometry; Board Certification; Cancer Center; Cancer Control; Cancer Patient; Clinical; Clinical Informatics; Clinical Research; Clinical Services; Clinics and Hospitals; Collaborations; Communities; Community Practice; Computerized Medical Record; County Hospitals; Data; Data Analyses; Data Collection; Data Management Resources; Data Science; Data Security; Data Set; Data Storage and Retrieval; Databases; Delaware; Development; Doctor of Medicine; Ecosystem; Engineering; Ensure; Ethnic Origin; Female; Future; General Hospitals; Gynecology; Hematology; Hospitals; Informatics; Infrastructure; Internal Medicine; Laboratories; Latinx; Leadership; Link; Malignant Neoplasms; Medicaid; Medical; Medical center; Medicine; Methods; New Jersey; Oncologist; Oncology; Operative Surgical Procedures; Oral; Pathology; Patients; Pennsylvania; Pilot Projects; Population; Presbyterian Church; Protocols documentation; Race; Radiation Oncology; Radiology Specialty; Research; Research Personnel; Resources; Sampling; Sampling Studies; Secure; Security; Selection Criteria; Services; Site; Standardization; Structure; System; Testing; Tobacco use; Translational Research; Uninsured; Universities; University Hospitals; Wisconsin; Work; behavioral economics; cancer care; chemotherapy; clinical center; clinical research site; clinical training; clinically relevant; community based practice; computer science; data dissemination; data management; data sharing; design; electronic recording system; evidence base; experience; forging; implementation science; implementation strategy; improved; innovation; interoperability; member; operation; patient population; programs; recruit; research study; scale up; socioeconomic diversity; therapy adherence

The Implementation Laboratory (IL) for the University of Pennsylvania Implementation Science Center in Cancer Control (Penn ISC3) will provide the fundamental infrastructure, technical assistance, and leadership to ensure access to the populations needed to complete the planned and future studies within the Research Program and the informatics and data management organization to execute and complete these studies. The overall Director for the IL will be Lawrence N. Shulman, M.D., Deputy Director for Clinical Services of the Abramson Cancer Center (ACC) at Penn and Director of the Center for Global Cancer Medicine. He oversees strategic develop- ment of cancer services for the ACC and its affiliated hospitals and clinics (i.e., all members of the IL) and leads the Cancer Quality program for Penn Medicine, which oversees system-wide initiatives designed to improve the quality of cancer care. MPI Dr. Justin Bekelman will co-lead the IL with Dr. Shulman. The overarching objective of the IL will be to manage the diverse clinical sites that provide cancer care under Penn Medicine to ensure the successful completion of the planned and future studies in the Research Program and to oversee the Penn ISC3 informatics and data management infrastructure. Penn Medicine includes five hospitals (the Hospital of the Uni- versity of Pennsylvania, the Penn Presbyterian Medical Center, Pennsylvania Hospital, Chester County Hospital, and Lancaster General Hospital, and four community-based cancer practices (Regional Hematology Oncology Associates, Valley Forge Medical Center, Radnor Medical Center [staffed by clinicians from Pennsylvania Hos- pital], and Cherry Hill Medical Center). Within these 9 sites, there are over 200 clinicians that serve more than 15,000 new cancer patients annually. Since the Research Program will rely heavily on the electronic medical record (EMR) for implementation strategy delivery and data collection, the IL will also provide the leadership, technical assistance, and resources needed in clinical informatics. Dr. Peter Gabriel, Chief Oncology Informatics Officer (COIO) for Penn Medicine, and Associate Director for Data Science for the ACC, and his team will provide leadership, technical assistance, and resources for the Center’s clinical informatics needs, including the design and implementation of strategies implemented through the EMR and data collection through the EMR. Lastly, the IL will be comprised of data management support and resources under the direction of Ms. Sue Ware, the director of the Data Management Unit (DMU) for the Center. The DMU will provide systems for data collection, data storage and security, data management, provide datasets for biostatistical support and data sharing/dis- semination. Overall, the IL will ensure that the Penn ISC3 has the requisite leadership and access to the clinicians and patients to ascertain their study samples, has the needed clinical informatics support and resources to de- sign and execute the proposed implementation strategies through the EMR, and has the essential data manage- ment organization to ensure the complete and safe ascertainment of data for the proposed data analyses and dissemination. PHS 398/2590 (Rev. 06/09) Page Continuation Format Page

宾夕法尼亚大学癌症实施科学中心的实施实验室（IL） 控制（Penn ISC 3）将提供基本的基础设施，技术援助和领导，以确保 接触完成研究计划内计划和未来研究所需的人群， 信息学和数据管理组织负责执行和完成这些研究。总导演 他将是劳伦斯·N。舒尔曼，医学博士，艾布拉姆森癌症中心临床服务副主任 中心（ACC）在宾夕法尼亚大学和全球癌症医学中心主任。他负责战略发展- 为ACC及其附属医院和诊所提供癌症服务（即，IL的所有成员）和电极导线 宾夕法尼亚大学医学院的癌症质量计划，该计划负责监督旨在改善 癌症护理的质量。MPI博士Justin Bekelman将与Shulman博士共同领导IL。首要目标 IL将管理在宾夕法尼亚医学下提供癌症护理的各种临床站点，以确保 成功完成研究计划中计划和未来的研究，并监督Penn ISC 3 信息学和数据管理基础设施。宾州医学包括五家医院（大学医院）， 宾夕法尼亚大学，宾夕法尼亚长老会医疗中心，宾夕法尼亚医院，切斯特县医院， 和兰开斯特总医院，以及四个以社区为基础的癌症实践（区域血液肿瘤学 助理，福吉谷谷医疗中心，拉德诺医疗中心[由来自宾夕法尼亚州的临床医生组成， Pital]和Cherry Hill Medical Center）。在这9个站点中，有200多名临床医生， 每年新增15,000名癌症患者。由于研究计划将严重依赖电子医疗 记录（EMR）的实施战略交付和数据收集，IL还将提供领导， 临床信息学所需的技术援助和资源。Peter Gabriel博士，肿瘤信息学主任 Penn Medicine的官员（COIO）和ACC的数据科学副主任及其团队将提供 领导，技术援助和资源中心的临床信息学的需求，包括设计 以及通过EMR实施的战略的实施和通过EMR收集的数据。最后， IL将由Sue Ware女士领导的数据管理支持和资源组成， 中心数据管理单元（DMU）主任。DMU将提供数据收集系统， 数据存储和安全，数据管理，为生物统计支持和数据共享提供数据集/DIS- 人工授精总的来说，IL将确保Penn ISC 3拥有必要的领导能力和接触临床医生的机会 和病人，以确定他们的研究样本，有必要的临床信息学支持和资源， 通过EMR签署并执行建议的实施策略，并拥有必要的数据管理- 测量组织，以确保完整和安全地确定拟议数据分析的数据， 传播。 PHS 398/2590（Rev.06/09）